About Polytherics
Polytherics is a Healthcare company based in Cambridge (United Kingdom) founded in 2002. Biomedical polymers and conjugation technologies for biopharmaceuticals are developed. Polytherics has raised $12.56 million across 5 funding rounds from investors including Mercia, YFM Equity Partners and Invesco Perpetual. Polytherics has completed 1 acquisition, including Warwick Effect Polymers. Polytherics offers products and services including Antibody Discovery, Cell Line Development, Bioconjugate Development, and Analytics and Bioassays. Its focus areas include Biopharma Outsourcing, CDMO and Biologics. Its legal entity is ABZENA LIMITED.
Company details
Polytherics was founded in 2002 in Cambridge, United Kingdom, as a developer of biomedical polymers and proprietary technologies for biopharmaceutical applications. Site-specific conjugation methods, including PEGylation and TheraPEG, were utilized for antibody-drug conjugates and protein-based drugs. A portfolio of products such as cytokines, antibodies, enzymes, hormones, peptides, and blood proteins was maintained. Services for immunogenicity assessment and protein engineering were integrated following a 2013 merger with Antitope to form Abzena.
- Headquarters Cambridge, United Kingdom
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website polytherics.co.uk
- Social LinkedIn X
- Legal Name Abzena Limited
- Date of Incorporation 25 Mar, 2014
- Jurisdiction CAMBRIDGE
- Annual Revenue$2.62 M (USD)109as on Dec 31, 2016
- Net Profit$363.26 K (USD)-42as on Dec 31, 2016
- Total Equity Funding$12.56M (USD)
in 5 rounds
- InvestorsMercia
& 5 more
- Investments & Acquisitions
Products & Services of Polytherics
Polytherics offers a comprehensive portfolio of products and services, including Antibody Discovery, Cell Line Development, Bioconjugate Development, and Analytics and Bioassays.
Service for developing high-affinity antibodies with desired activity.
Generates cell lines for biologics production and GMP compliance.
Designs and develops ADCs, AOCs, and RDCs for drug advancement.
Performs method development and assays for biologic characterization.
Funding Insights of Polytherics
Polytherics has successfully raised a total of $12.56M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $12.56M
- Total Rounds 5
- First Round $4.57M
(Jun 2007)
- Investors Count 6
All 5 funding rounds of Polytherics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2013 | Series A | – | – | ||
| Sep 2011 | $3.45M | Series A | – | – | |
| Feb 2010 | $4.54M | Series A | – | – | |
| Nov 2007 | $724,573 | Grant | – | – | – |
| Jun 2007 | $4.57M | Series A | – | – |
6 investors in total: 6 institutional.
Investors in Polytherics
Polytherics has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Mercia, YFM Equity Partners and Invesco Perpetual.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments in startups are focused on Europe and the US. | 1986 | imperialinnovations.co.uk | London, United Kingdom | |
Private equity firm focused on multiple sectors | 1982 | yfmep.com | Leeds, United Kingdom | |
| longbow.co.uk | ||||
Diversified investment management services are provided globally. | 1973 | invescoperpetual.co.uk | ||
Investment management services are provided by Mercia to various clients. | 1982 | mercia.co.uk | ||
Tax-efficient investment opportunities are provided by ProVen for retail investors. | provenvcts.co.uk | London, United Kingdom |
Investor details for Polytherics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Polytherics
Polytherics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Warwick Effect Polymers.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Complex polymers are manufactured via living controlled radical polymerization. | warwickeffectpolymers.co.uk | Coventry, United Kingdom | 2001 | Jan 2012 | •••• |
Complete acquisition details for Polytherics
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Polytherics
4 dated milestones of Polytherics across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Polytherics is founded.
- Funding First funding round of $4.6M.
- Acquisition Acquires Warwick Effect Polymers.
- Funding Latest funding round, Series A,.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Polytherics
Complete news archive for Polytherics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Polytherics
Polytherics was founded in 2002 and raised its 1st funding round 5 years after it was founded.
Polytherics is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Polytherics is a funded company, having raised a total of $12.56M across 5 funding rounds to date. The company's 1st funding round was a Series A of $4.57M, raised on Jun 2007.
Annual revenue of Polytherics is $2.62M as on Dec 31, 2016.
Polytherics was founded in 2002 in Cambridge, United Kingdom, as a developer of biomedical polymers and proprietary technologies for biopharmaceutical applications. Site-specific conjugation methods, including PEGylation and TheraPEG, were utilized for antibody-drug conjugates and protein-based drugs. A portfolio of products such as cytokines, antibodies, enzymes, hormones, peptides, and blood proteins was maintained. Services for immunogenicity assessment and protein engineering were integrated following a 2013 merger with Antitope to form Abzena.
Polytherics offers Antibody Discovery, Cell Line Development, Bioconjugate Development, and Analytics and Bioassays.
Polytherics has made 1 acquisition, including Warwick Effect Polymers.
Polytherics has 6 investors. Key investors include Mercia, YFM Equity Partners, Invesco Perpetual, Imperial Innovations, and ProVen.
Polytherics operates through Abzena Limited.